Patent details

EP2898885 Title: Pyrrolopyrimidine derivatives for use in the treatment of viral infections

Basic Information

Publication number:
EP2898885
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP141981258
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pyrrolopyrimidine derivatives for use in the treatment of viral infections
French Title of Invention:
Dérivés de la pyrrolopyrimidine pour leur utilisation dans le traitement d'infections virales
German Title of Invention:
Pyrrolopyrimidin-Derivate zur Verwendung bei der Behandlung von viralen Infektionen
SPC Number:

Dates

Filing date:
14/10/2011
Grant date:
22/11/2017
EP Publication Date:
29/07/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/11/2017
EP B1 Publication Date:
22/11/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/10/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/11/2017
 
 

Name:
Biocryst Pharmaceuticals, Inc.
Address:
4505 Emperor Blvd., Durham, North Carolina 27703, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
10/01/2018
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Bantia, Shanta
Address:
United States (US)

2

Name:
Babu, Yarlagadda S
Address:
United States (US)

3

Name:
Kotian, Pravin L
Address:
United States (US)

Priority

1

Priority Number:
393522 P
Priority Date:
15/10/2010
Priority Country:
United States (US)

2

Priority Number:
201161492054 P
Priority Date:
01/06/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/215; A61K 31/519; A61K 45/06; A61P 31/14;

Publication

European Patent Bulletin

Issue number:
201747
Publication date:
22/11/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/10/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
SUN IP LLC
Filing date Document type Number of pages
10/01/2018 Power Of Attorney 1
29/01/2018 Outgoing Correspondence 1